(Total Views: 467)
Posted On: 03/13/2020 6:38:03 PM
Post# of 72440
Brilacidin by Innovation Pharmaceuticals
Innovation Pharmaceuticals announced that it is evaluating Brilacidin, a defensin mimetic drug candidate, as a potential treatment for coronavirus. Brilacidin has shown antibacterial, anti-inflammatory and immunomodulatory properties in several clinical trials.
The company is planning to explore research collaborations and seek federal grants to develop the coronavirus drug. It is already investigating the drug for inflammatory bowel disease and oral mucositis in cancer patients.
Innovation has signed two material transfer agreements with a university in the US and biocontainment labs in the US for evaluation of Brilacidin as a treatment for Covid-19.
Innovation Pharmaceuticals announced that it is evaluating Brilacidin, a defensin mimetic drug candidate, as a potential treatment for coronavirus. Brilacidin has shown antibacterial, anti-inflammatory and immunomodulatory properties in several clinical trials.
The company is planning to explore research collaborations and seek federal grants to develop the coronavirus drug. It is already investigating the drug for inflammatory bowel disease and oral mucositis in cancer patients.
Innovation has signed two material transfer agreements with a university in the US and biocontainment labs in the US for evaluation of Brilacidin as a treatment for Covid-19.
(2)
(1)Scroll down for more posts ▼
